NCT05394935

Brief Summary

This study will investigate the impact of high- and moderate-intensity exercise on the cardiometabolic and brain health of women with Polycystic Ovary syndrome (PCOS). The aim is to measure and compare normal, healthy women without PCOS, to those with the condition. All participants will undergo a blood test. The investigators will then assess the participants cardiovascular fitness by means of a maximal exercise test and measure body composition through height, weight, and hip-to-waist ratio. Participants will undergo an MRI, where the investigators will assess the participants brain structure and how the brain responds to a number of tests. The investigators will also conduct some tests that will assess the participants cognition, such as IQ, memory etc. The investigators will measure the blood vessels leading to the brain and the blood flow through them to measure how much blood the brain receives when rested, using ultrasound. The investigators will use a number of tests to look at brain function, measure the responses to these tests, and compare them between the normal, healthy women and those with PCOS. This will show if women with PCOS have a similar brain function when rested and when their brains are tested to those without the condition. The investigators will use exercise as an intervention, where the aim will be to investigate whether women with PCOS respond similarly to those without the condition to both high-intensity and moderate-intensity exercise. The tests of brain function will be repeated following the exercise, and see if both normal, healthy women and those with PCOS have a similar response to the brain function tests. All tests and measures will be compared between the PCOS group, and the healthy control group to establish any potential differences or similarities as a result of the condition.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2020

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

February 10, 2022

Completed
4 months until next milestone

First Posted

Study publicly available on registry

May 27, 2022

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 25, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 25, 2024

Completed
Last Updated

February 13, 2025

Status Verified

February 1, 2025

Enrollment Period

4.4 years

First QC Date

February 10, 2022

Last Update Submit

February 11, 2025

Conditions

Keywords

PCOSPolycystic Ovary SyndromeExerciseHigh-Intensity Interval TrainingModerate-Intensity Steady StateCerebrovascular

Outcome Measures

Primary Outcomes (8)

  • Cerebrovascular Reactivity to Carbon Dioxide (CO2)

    6% CO2 administered to measure reactivity of the cerebrovasculature as measured by extra-cranial ultrasonography.

    Baseline

  • Cerebrovascular Reactivity to Carbon Dioxide (CO2)

    6% CO2 administered to measure reactivity of the cerebrovasculature as measured by extra-cranial ultrasonography.

    Less than 1 hour post-exercise

  • Neurovascular coupling (NVC)

    NVC will be assessed using a visual task (flashing checkerboard) measured via transcranial Doppler.

    Baseline

  • Neurovascular coupling (NVC)

    NVC will be assessed using a visual task (flashing checkerboard) measured via transcranial Doppler.

    Less than 1 hour post-exercise

  • Dynamic cerebral autoregulation (dCA)

    dCA will be assessed using a squat-stand method to induce forced oscillations in blood pressure and measured using finger plethysmography and transcranial Doppler.

    Baseline

  • Dynamic cerebral autoregulation (dCA)

    dCA will be assessed using a squat-stand method to induce forced oscillations in blood pressure and measured using finger plethysmography and transcranial Doppler.

    Less than 1 hour post-exercise

  • Cerebral blood velocity in the middle (MCAv) and posterior cerebral arteries (PCAv) during exercise

    MCAv and PCAv will be assessed using transcranial Doppler and employed throughout both bouts of acute exercise.

    During high-intensity exercise (24 minutes)

  • Cerebral blood velocity in the middle (MCAv) and posterior cerebral arteries (PCAv) during exercise

    MCAv and PCAv will be assessed using transcranial Doppler and employed throughout both bouts of acute exercise.

    During moderate-intensity exercise (50 minutes)

Secondary Outcomes (10)

  • Cardiorespiratory fitness (CRF)

    Baseline

  • Cerebral structure

    Baseline

  • Cerebral blood flow

    Baseline

  • Cerebral metabolic rate of oxygen consumption

    Baseline

  • Cerebrovascular reactivity

    Baseline

  • +5 more secondary outcomes

Study Arms (2)

Polycystic Ovary Syndrome

EXPERIMENTAL

Women with PCOS

Other: High-Intensity ExerciseOther: Moderate-Intensity Exercise

Controls

ACTIVE COMPARATOR

Healthy, age and BMI matched controls

Other: High-Intensity ExerciseOther: Moderate-Intensity Exercise

Interventions

Acute, low-volume HIIT 12x (1min:1min) Working intensity: \>85% heart rate reserve Resting intensity: Active rest

ControlsPolycystic Ovary Syndrome

Continuous, MISS 50mins Working intensity: 50-60% heart rate reserve

ControlsPolycystic Ovary Syndrome

Eligibility Criteria

Age16 Years - 50 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsFemales with PCOS and healthy females acting as a controls. Eligibility of participants is via biological sex.
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Polycystic Ovary Syndrome as diagnosed by any recognised criteria.
  • Inactive (less than 40 mins of structured exercise per week).

You may not qualify if:

  • Pregnant or breastfeeding.
  • Congenital adrenal hyperplasia, Cushing's syndrome, thyroid disease, hyperprolactinaemia and androgen secreting tumours.
  • Known history of cardiovascular disease.
  • Contraindications to MRI (fitted with ferromagnetic devices).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cardiff Metropolitan University

Cardiff, CF242SX, United Kingdom

Location

MeSH Terms

Conditions

Polycystic Ovary SyndromeMotor Activity

Interventions

High-Intensity Interval Training

Condition Hierarchy (Ancestors)

Ovarian CystsCystsNeoplasmsOvarian DiseasesAdnexal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesGonadal DisordersEndocrine System DiseasesBehavior

Intervention Hierarchy (Ancestors)

Physical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
All participant data and exercise arm will be anonymised and non-identifiable by the assessor.
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Participants will complete multiple baseline assessments. Within the crossover model, participants will complete a baseline cerebrovascular assessment, followed by a random bout of acute exercise and then a post-exercise repeat of the baseline tests. Following a pre-designated washout, the participants will complete the same visit with the remaining exercise bout.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 10, 2022

First Posted

May 27, 2022

Study Start

January 1, 2020

Primary Completion

May 25, 2024

Study Completion

May 25, 2024

Last Updated

February 13, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will share

Applications for access to study- and participant-level data will be considered on direct enquiry.

Shared Documents
ANALYTIC CODE
Time Frame
January 2024 - 5 years

Locations